Effects of 3.7 T–24.5 T high magnetic fields on tumor-bearing mice
Tian Xiaofei1, 2, Wang Ze1, 3, Zhang Lei1, Xi Chuanying1, Pi Li1, Qi Ziping1, Lu Qingyou1, 3, 4, ‡, Zhang Xin1, 2, §
       

(color online) Blood routine test results for 3.7 T–24.5 T high magnetic field-treated GIST-T1 tumor-bearing mice. (a), (b) The concentration of red blood cell (RBC), platelet (PLT), white blood cell (WBC); (c) mean corpuscular volume (MCV) and mean platelet volume (MPV); (d) hemoglobin concentration (HGB) and mean corpuscular hemoglobin concentration (MCHC); (e), (f), (g) percentage of hematocrit (HCT), thrombocytocrit (PCT), lymphocyte (LYMPH), monocyte (MONO), neutrophil (NEUT), and eosinophil (EO) were measured for each mouse. For control (CT), the mean value from eight mice was used. The blue shaded area means the mice were under the circumstances of “hypogravity”. The pink shaded area shows the mice were under the circumstances of “hypergravity”. The green shaded area shows the reference range defined by eight mice in the Sham control group. (h) The relative levels of MCV, MCHC, HCT%, RBC, LYMPH%, NEUT%, and WBC were compared between Sham control, 24.5 T (no gradient), and 7.2 T (in hypogravity and hypergravity conditions).